Harrold

Jimmy's Jazz & Blues Club Features GRAMMY® Award-Winning Trumpeter & Composer KEYON HARROLD on Friday June 9 at 7:30 P.M.

Retrieved on: 
Wednesday, May 24, 2023
Online, Ticketmaster, Calendar, Music, ALL, Hip hop music, Element, Common, R&B, Composer, Cookers, The New School, NEA Jazz Masters, Miles Ahead, Keyon Harrold, Harrold, R, Family, Nightclub, Eminem, Jazz

PORTSMOUTH, N.H., May 24, 2023 /PRNewswire/ -- Jimmy's Jazz & Blues Club Features GRAMMY® Award-Winning Trumpeter and Composer KEYON HARROLD and his Acclaimed Quintet at Jimmy's Jazz & Blues Club on Friday June 9 at 7:30 P.M. Keyon Harrold has received wide critical acclaim for his skill as a trumpeter and composer, while Wynton Marsalis calls him "the future of the trumpet."

Key Points: 
  • GRAMMY® Award-Winning Trumpeter Keyon Harrold won wide acclaim for his trumpet performances in Don Cheadle's Miles Davis biopic "Miles Ahead".
  • The NEW YORK TIMES calls Harrold "a scorching trumpeter" while ALL ABOUT JAZZ describes him as "a serious player among equals."
  • PORTSMOUTH, N.H., May 24, 2023 /PRNewswire/ -- Jimmy's Jazz & Blues Club Features GRAMMY® Award-Winning Trumpeter and Composer KEYON HARROLD and his Acclaimed Quintet at Jimmy's Jazz & Blues Club on Friday June 9 at 7:30 P.M. Keyon Harrold has received wide critical acclaim for his skill as a trumpeter and composer, while Wynton Marsalis calls him "the future of the trumpet."
  • Keyon Harrold grew up one of 16 children in a family that prioritized music and community across generations.

ENVX DEADLINE TOMORROW: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys Before Mar. 7th Deadline in Securities Class Action

Retrieved on: 
Monday, March 6, 2023
Hagens Berman, SAN, Silicon, Harrold, Cybook Gen1, Complaint, Person, Life insurance, Video game, Pharmaceutical industry

SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys Before Mar. 7th Deadline in Securities Class Action

Retrieved on: 
Monday, February 27, 2023
Cybook Gen1, Corporation, Silicon, Person, Harrold, Hagens Berman, Complaint, Video game, Pharmaceutical industry

Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.

Key Points: 
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • The company also revealed that it was pivoting to and prioritizing its next generation manufacturing lines and expected lower overall Fab-1 output in 2023.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Pending

Retrieved on: 
Monday, February 20, 2023
Person, Cybook Gen1, Harrold, Hagens Berman, Complaint, SAN, Silicon, Cryptocurrency, Video game, Pharmaceutical industry

SAN FRANCISCO, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Monday, February 13, 2023
Person, Cybook Gen1, Harrold, Hagens Berman, Complaint, SAN, Silicon, Cryptocurrency, Video game, Pharmaceutical industry

SAN FRANCISCO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Lawsuit Pending

Retrieved on: 
Monday, February 6, 2023
Person, Harrold, Complaint, Cybook Gen1, Silicon, SAN, Steve Berman (lawyer), Risk management, Pharmaceutical industry

SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Enovix Corporation (ENVX) Investors to Filing of Securities Class Action, Encourages Investors with Significant Losses to Contact Firm’s Attorneys

Retrieved on: 
Monday, January 30, 2023
Person, Harrold, Complaint, Cybook Gen1, Silicon, SAN, Steve Berman (lawyer), Risk management, Pharmaceutical industry

SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Monday, January 23, 2023
Person, Harrold, Complaint, Cybook Gen1, Silicon, SAN, Steve Berman (lawyer), Pharmaceutical industry, Risk management

SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Monday, January 16, 2023
Harrold, Silicon, Person, Steve Berman (lawyer), Complaint, SAN, Cybook Gen1, Risk management, Pharmaceutical industry

SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX ALERT: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Wednesday, January 11, 2023
Harrold, Silicon, Person, Steve Berman (lawyer), Complaint, SAN, Cybook Gen1, Risk management, Pharmaceutical industry

SAN FRANCISCO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .